NYSE$RYAN

Ryan Specialty Group Holdings, Inc. · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Ryan Specialty reported strong revenue growth but faced a decline in net income for Q4 2024.

Ryan Specialty Holdings reported a 24.5% year-over-year increase in revenue to $663.5 million. However, net income fell by 27.3% to $42.6 million due to higher expenses. Adjusted net income rose by 28.9% to $123.3 million, and adjusted diluted EPS increased to $0.45. The company also achieved an 11.0% organic revenue growth rate.

  • Revenue grew 24.5% year-over-year to $663.5 million.
  • Net income declined 27.3% to $42.6 million due to increased expenses.
  • Adjusted net income increased 28.9% to $123.3 million.
  • Organic revenue growth rate was 11.0% for the quarter.

Headline financials

Total Revenue

$664M

Previous: $533M+24.5%
EPS (adj)

$0.45

Previous: $0.35+28.6%
Organic Revenue Growth

11.0%

No prior period
Net Income

$42.6M

Previous: $58.5M-27.3%
Operating Income

$109M

No prior period

Revenue & EPS history

Ryan Specialty Group · Revenue · Quarterly

$664M

Q4 2024+24.5%vs Q4 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

Ryan Specialty Group · $408M total across 3 segments · Q3 2022

  • Wholesale Brokerage
    $267M+16.6%
  • Underwriting Management
    $84.7M+19.9%
  • Binding Authority
    $55.6M+5.3%

Forward guidance

Ryan Specialty expects continued revenue growth in 2025, with organic revenue growth projected between 11.0% and 13.0%, and an adjusted EBITDAC margin of 32.5% to 33.5%.

Tailwinds

  • Organic revenue growth guidance for FY25 is 11.0% - 13.0%.
  • Adjusted EBITDAC margin projected at 32.5% - 33.5%.
  • Continued expansion through M&A strategy.
  • Strong demand for specialty insurance products.
  • Operational efficiencies expected to support margin expansion.

Headwinds

  • Higher operating expenses may impact profitability.
  • Interest expenses expected to remain elevated.
  • Macroeconomic uncertainties could affect growth.
  • Competitive pressures in the specialty insurance market.
  • Foreign exchange fluctuations could impact revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 17 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

-0.3%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+3.5%

Avg return

30 days after

50%

9 / 18 earnings

Positive

+11.6%

Q1 2022

Best reaction

-22.5%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-10.5%-15.5%-8.6%
Q3 2025+8.1%+9.4%+14.6%
Q1 2025+3.2%+9.4%+10.4%
Q4 2024-4.7%+0.6%+3.6%
Q3 2024-5.9%-3.5%+7.7%
Q2 2024+11.3%+4.7%+4.9%
Q1 2024-1.8%-0.5%+5.9%
Q4 2023+7.8%+13.9%+17.9%
Q3 2023+2.6%+2.6%+4.5%
Q2 2023-2.0%-1.6%+11.1%
Q1 2023+2.8%+5.3%+2.1%
Q4 2022-3.8%-5.2%-7.9%
Q3 2022-22.5%-22.7%-7.0%
Q2 2022-0.6%+0.4%-5.9%
Q1 2022+11.6%+13.3%+5.6%
Q4 2021-10.7%-7.9%+0.3%
Q3 2021+7.5%+2.2%+2.3%
Q2 2021+2.4%+4.7%+1.8%
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro